This segment focuses on the distribution of branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter healthcare products. Cardinal Health provides supply chain solutions, including warehousing, inventory management, and delivery services to pharmacies, hospitals, and other healthcare providers. The company also offers services to pharmaceutical manufacturers, such as product distribution, and provides medication therapy management and pharmacy management services. Research and development activities include optimizing distribution networks, improving medication adherence programs, and exploring new technologies for pharmaceutical supply chain efficiency. This segment addresses the critical need for reliable and efficient drug delivery, impacting patient access to medications and improving health outcomes. Cardinal Health's market position is strong due to its extensive distribution network and established relationships with pharmaceutical manufacturers and healthcare providers. Future opportunities include expanding specialty pharmacy services and leveraging data analytics to improve supply chain efficiency and patient outcomes. Regulatory compliance and adherence to pharmaceutical regulations are critical aspects of this segment, ensuring the safety and efficacy of distributed medications. Partnerships with pharmaceutical companies and healthcare providers are essential for success.

This segment encompasses the manufacturing, sourcing, and distribution of Cardinal Health branded medical, surgical, and laboratory products and devices. These include a wide range of products such as gloves, needles, surgical drapes, and wound care products. The segment also distributes national brand products and provides supply chain services to hospitals, ambulatory surgery centers, and clinical laboratories. Research and development efforts focus on improving product design, enhancing material science, and developing innovative medical devices. Technologies used include advanced manufacturing processes, sterilization techniques, and supply chain management systems. This segment serves a broad range of therapeutic areas, including surgery, wound care, and infection prevention, directly impacting patient safety and the efficiency of healthcare operations. Cardinal Health's market position is strong due to its diverse product portfolio and established distribution network. Future opportunities include expanding into new medical device categories and leveraging digital technologies to improve supply chain efficiency and patient care. Regulatory compliance, including FDA approvals and adherence to quality standards, is critical. Partnerships with healthcare providers and medical technology companies are essential for innovation and market access.

This segment focuses on providing radiopharmaceuticals and related services for diagnostic imaging and therapeutic applications. Cardinal Health operates nuclear pharmacies and radiopharmaceutical manufacturing facilities, providing products and services to hospitals and clinics. Research and development activities include the development of new radiopharmaceuticals, improving imaging techniques, and exploring the use of radiopharmaceuticals in targeted therapies. Technologies used include advanced imaging equipment, radiopharmaceutical production processes, and supply chain management for radioactive materials. This segment serves the therapeutic areas of oncology, cardiology, and neurology, enabling the diagnosis and treatment of various diseases. Patient impact includes improved diagnostic accuracy and targeted therapies. Cardinal Health's market position is strong due to its established infrastructure and expertise in radiopharmaceutical production and distribution. Future opportunities include expanding the product portfolio, developing new imaging agents, and exploring the use of radiopharmaceuticals in personalized medicine. Regulatory compliance with nuclear safety regulations and FDA approvals is critical. Partnerships with pharmaceutical companies and healthcare providers are essential for clinical trials and market access.